Clearance Summary
THERAPAX DXT 300 SERIES 3 received FDA 510(k) clearance under submission number K923584, sponsored by Oldelft Corp. of America. The device was reviewed via the Traditional premarket notification pathway and assigned to the Radiology review panel. The statutory decision date of record is 1993-01-15.
- Submission: K923584
- Applicant / Sponsor: Oldelft Corp. of America
- Clearance pathway: Traditional
- Review panel: Radiology
- Device class: Class II
- Regulation citation: 21 CFR 892.5900
- Decision date: 1993-01-15
Classification & Regulation
This clearance is catalogued under FDA product code JAD and 21 CFR 892.5900, within the Radiology review panel as a Class II device.